Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma

In the LIONESS peer-reviewed cohort of 17 surgical HNSCC patients, ctDNA was detected in all baseline samples and, in every clinical recurrence, was detected first, with lead times of 108 to 253 days.

Br J CancerPubMed 35132238DOI 10.1038/s41416-022-01716-7